A synergistic blend of CJC-1295 No DAC (5MG) and Ipamorelin (5MG) targeting dual stimulation of growth hormone release via GHRH receptor agonism and ghrelin receptor activation. Research demonstrates enhanced GH pulse amplitude with this combination.
| Blend Ratio | 5MG CJC-1295 + 5MG Ipamorelin |
| CAS CJC-1295 | 863288-34-0 |
| CAS Ipamorelin | 170851-70-4 |
| Form | Lyophilized powder |
| Purity | ≥99% |
| Vial | 6ML sealed flip-top |